With patient-centricity a guiding principle, more sponsors are looking to virtual or hybrid clinical trials to engage those patients who would not have ordinarily made the decision to participate.
The COVID-19 pandemic has changed our way of life, including the way in which we conduct clinical trials. With patient-centricity a guiding principle, more sponsors are looking to virtual or decentralized hybrid clinical trials to engage those patients who would not have ordinarily made the decision to participate.
This month’s edition of Voyager showcases insights accumulated from conducting a wide-range of virtual clinical trials, along with perspectives on the surprising impact a clinical database has on the success of COVID-19 studies.
Webinar: How to Better Plan Your Virtual Trial - Lessons Learned
Veristat understands pivoting to virtual or decentralized hybrid clinical trials is challenging. Our customized virtual/hybrid trial ecosystem satisfies the needs of regulators, sponsors and patients.
Hear our panelists share lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials’ conduct.
Article: Accelerating Clinical Trial Design and Operations
Veristat’s Ryad Ramda and Cindy Henderson were among the authors of a study whose findings were published in a recent article in Applied Clinical Trials. The study demonstrated that a cloud-based CDMS supported the rapid execution of a vaccine and a therapeutic drug trial during the COVID-19 pandemic.
Veristat is now part of the Barcelona Health Hub—an ecosystem for the digital transformation of health— as our clinical trial activities in Europe continue to grow. Take a tour with our VP of Europe, Montse Barceló Riera, and hear the latest from the front lines of España.
The FDA recently updated its guidance for industry, investigators, and Institutional Review Boards during the COVID-19 public health emergency. Learn more
Follow Veristat
Stay current with the latest news from Veristat by following us on social media using the links below.
